Abstract Details
|
PRESENTER |
No disclosure on file |
| David Y. Hwang, MD, FÂé¶¹´«Ã½Ó³» (University of North Carolina School of Medicine) | The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. The institution of an immediate family member of Dr. Hwang has received research support from NIH. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Director - Critical Care with New England Donor Services. |
| No disclosure on file | |
| No disclosure on file | |
| Brigitte Wildemann, MD (University Hospital Heidelberg, Department of Neurology) | The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand. |